Illinois General Assembly - Full Text of HB0707
Illinois General Assembly

Previous General Assemblies

Full Text of HB0707  100th General Assembly

HB0707 100TH GENERAL ASSEMBLY

  
  

 


 
100TH GENERAL ASSEMBLY
State of Illinois
2017 and 2018
HB0707

 

Introduced 1/25/2017, by Rep. Patricia R. Bellock

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/406  from Ch. 56 1/2, par. 1406

    Amends the Illinois Controlled Substances Act. Provides various penalties for knowingly withholding information from a practitioner from whom a person seeks to obtain a controlled substance or a prescription for a controlled substance. Provides that a health care practitioner with the intent to provide a controlled substance or combination of controlled substances that are not medically necessary to his or her patient or an amount of controlled substances that is not medically necessary for his or her patient, may not provide a controlled substance or a prescription for a controlled substance by misrepresentation, fraud, forgery, deception, subterfuge, or concealment of a material fact. Provides that a violation is a Class 4 felony for the first offense and a Class 3 felony for each subsequent offense. The fine for the first offense shall be not more than $100,000. The fine for each subsequent offense shall not be more than $200,000.


LRB100 07069 RLC 17123 b

CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB0707LRB100 07069 RLC 17123 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 406 as follows:
 
6    (720 ILCS 570/406)  (from Ch. 56 1/2, par. 1406)
7    Sec. 406. (a) It is unlawful for any person:
8        (1) who is subject to Article III knowingly to
9    distribute or dispense a controlled substance in violation
10    of Sections 308 through 314.5 of this Act; or
11        (2) who is a registrant, to manufacture a controlled
12    substance not authorized by his or her registration, or to
13    distribute or dispense a controlled substance not
14    authorized by his or her registration to another registrant
15    or other authorized person; or
16        (3) to refuse or fail to make, keep or furnish any
17    record, notification, order form, statement, invoice or
18    information required under this Act; or
19        (4) to refuse an entry into any premises for any
20    inspection authorized by this Act; or
21        (5) knowingly to keep or maintain any store, shop,
22    warehouse, dwelling, building, vehicle, boat, aircraft, or
23    other structure or place, which is resorted to by a person

 

 

HB0707- 2 -LRB100 07069 RLC 17123 b

1    unlawfully possessing controlled substances, or which is
2    used for possessing, manufacturing, dispensing or
3    distributing controlled substances in violation of this
4    Act.
5    Any person who violates this subsection (a) is guilty of a
6Class A misdemeanor for the first offense and a Class 4 felony
7for each subsequent offense. The fine for each subsequent
8offense shall not be more than $100,000. In addition, any
9practitioner who is found guilty of violating this subsection
10(a) is subject to suspension and revocation of his or her
11professional license, in accordance with such procedures as are
12provided by law for the taking of disciplinary action with
13regard to the license of said practitioner's profession.
14    (b) It is unlawful for any person knowingly:
15        (1) to distribute, as a registrant, a controlled
16    substance classified in Schedule I or II, except pursuant
17    to an order form as required by Section 307 of this Act; or
18        (2) to use, in the course of the manufacture or
19    distribution of a controlled substance, a registration
20    number which is fictitious, revoked, suspended, or issued
21    to another person; or
22        (3) to acquire or obtain, or attempt to acquire or
23    obtain, possession of a controlled substance by
24    misrepresentation, fraud, forgery, deception or
25    subterfuge; or
26        (3.1) to withhold information requested from a

 

 

HB0707- 3 -LRB100 07069 RLC 17123 b

1    practitioner, with the intent to obtain a controlled
2    substance that has not been prescribed, by
3    misrepresentation, fraud, forgery, deception, subterfuge,
4    or concealment of a material fact; or
5        (3.2) to withhold information from a practitioner from
6    whom the person seeks to obtain a controlled substance or a
7    prescription for a controlled substance that the person
8    making the request has received a controlled substance or a
9    prescription for a controlled substance of like
10    therapeutic use from another practitioner within the
11    previous 30 days; or
12        (3.3) with the intent to obtain a controlled substance
13    or combination of controlled substances that are not
14    medically necessary for the person or an amount of a
15    controlled substance or substances that is not medically
16    necessary for the person, obtain or attempt to obtain from
17    a practitioner a controlled substance or a prescription for
18    a controlled substance by misrepresentation, fraud,
19    forgery, deception, subterfuge, or concealment of a
20    material fact. For purposes of this paragraph (3.3), a
21    material fact includes whether the person has an existing
22    prescription for a controlled substance issued for the same
23    period of time by another practitioner or as described in
24    paragraph (3.2) of this subsection (b); or
25        (4) to furnish false or fraudulent material
26    information in, or omit any material information from, any

 

 

HB0707- 4 -LRB100 07069 RLC 17123 b

1    application, report or other document required to be kept
2    or filed under this Act, or any record required to be kept
3    by this Act; or
4        (5) to make, distribute or possess any punch, die,
5    plate, stone or other thing designed to print, imprint or
6    reproduce the trademark, trade name or other identifying
7    mark, imprint or device of another, or any likeness of any
8    of the foregoing, upon any controlled substance or
9    container or labeling thereof so as to render the drug a
10    counterfeit substance; or
11        (6) (blank); or
12        (7) (blank).
13    Any person who violates this subsection (b) is guilty of a
14Class 4 felony for the first offense and a Class 3 felony for
15each subsequent offense. The fine for the first offense shall
16be not more than $100,000. The fine for each subsequent offense
17shall not be more than $200,000.
18    (b-5) A health care practitioner with the intent to provide
19a controlled substance or combination of controlled substances
20that are not medically necessary to his or her patient or an
21amount of controlled substances that is not medically necessary
22for his or her patient, may not provide a controlled substance
23or a prescription for a controlled substance by
24misrepresentation, fraud, forgery, deception, subterfuge, or
25concealment of a material fact. For purposes of this subsection
26(b-5), a material fact includes whether the patient has an

 

 

HB0707- 5 -LRB100 07069 RLC 17123 b

1existing prescription for a controlled substance issued for the
2same period of time by another practitioner or as described in
3paragraph (3.2) of subsection (b).
4    Any person or practitioner who violates the provisions of
5this subsection (b-5) is guilty of a Class 4 felony for the
6first offense and a Class 3 felony for each subsequent offense.
7The fine for the first offense shall be not more than $100,000.
8The fine for each subsequent offense shall not be more than
9$200,000.
10    (c) A person who knowingly or intentionally violates
11Section 316, 317, 318, or 319 is guilty of a Class A
12misdemeanor.
13(Source: P.A. 99-480, eff. 9-9-15.)